Learn more about Metalyse® 25 mg for the treatment of
acute ischaemic stroke
Explore the collection of available resources related to Metalyse® 25 mg, to help you in the
treatment and management of patients with AIS. Please use the links below to find the most
suitable resources for you.
For Doctors
Summary of Metalyse® 25 mg benefits
Administration
Efficacy and safety profile
Patient Journey
For Nurses
PDF Document for Preparation and Administration
Video for Preparation and Administration
For Pharmacists
Patient Education
General Resources
External Links
strokeforum.com
Strokeforum provides a wealth of educational resources, medical information on acute stroke management and prevention, and other useful resources for AIS.
Publications
Intravenous tenecteplase compared with alteplase for acute ischaemic stroke in Canada (AcT): a pragmatic, multicentre, open-label, registry-linked, randomised, controlled, non-inferiority trial
Menon B. K. et al. Lancet 2022; 400: 161–169.
Tenecteplase versus Alteplase before Thrombectomy for Ischemic Stroke
Campbell BCV, et al. N Engl J Med. 018;378:1573-82.
Evidence that Tenecteplase Is Noninferior to Alteplase for Acute Ischemic Stroke Meta-Analysis of 5 Randomized Trials
Burgos A. M. and Saver J. L. Stroke. 2019; 50:2156-2162.